186 related articles for article (PubMed ID: 24074925)
21. Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group.
Casey DL; Chi YY; Donaldson SS; Hawkins DS; Tian J; Arndt CA; Rodeberg DA; Routh JC; Lautz TB; Gupta AA; Yock TI; Wolden SL
Cancer; 2019 Sep; 125(18):3242-3248. PubMed ID: 31174239
[TBL] [Abstract][Full Text] [Related]
22. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
Casey DL; Wexler LH; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
[TBL] [Abstract][Full Text] [Related]
23. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608
[TBL] [Abstract][Full Text] [Related]
24. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Failure in Parameningeal Alveolar Rhabdomyosarcoma.
Bradley JA; Indelicato DJ; Uezono H; Morris CG; Sandler E; de Soto H; Mailhot Vega RB; Rotondo R
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):325-333. PubMed ID: 32044412
[TBL] [Abstract][Full Text] [Related]
26. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
[TBL] [Abstract][Full Text] [Related]
27. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Raney RB; Walterhouse DO; Meza JL; Andrassy RJ; Breneman JC; Crist WM; Maurer HM; Meyer WH; Parham DM; Anderson JR
J Clin Oncol; 2011 Apr; 29(10):1312-8. PubMed ID: 21357783
[TBL] [Abstract][Full Text] [Related]
28. Parameningeal rhabdomyosarcoma: results of an international workshop.
Benk V; Rodary C; Donaldson SS; Flamant F; Maurer H; Treuner I; Carli M; Gehan E
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):533-40. PubMed ID: 8948336
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and prognostic analysis of
Zhao D; Lyu XM; Chen P; Shi Y; Huang MW; Zheng L; Zhao WH; Ma XL; Zhang JG
Zhonghua Yi Xue Za Zhi; 2022 May; 102(20):1500-1505. PubMed ID: 35692064
[No Abstract] [Full Text] [Related]
30. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy.
Ladra MM; Mandeville HC; Niemierko A; Padera TP; Friedmann AM; MacDonald SM; Ebb D; Chen YL; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):358-67. PubMed ID: 25864172
[TBL] [Abstract][Full Text] [Related]
31. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma.
Raney B; Tefft M; Heyn R; Newton W; Jones PM; Haeberlen V; Maurer H
Cancer; 1992 Mar; 69(6):1498-506. PubMed ID: 1540886
[TBL] [Abstract][Full Text] [Related]
32. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Rodeberg DA; Wharam MD; Lyden ER; Stoner JA; Brown K; Wolden SL; Paidas CN; Donaldson SS; Hawkins DS; Spunt SL; Arndt CA
Int J Cancer; 2015 Jul; 137(1):204-11. PubMed ID: 25418440
[TBL] [Abstract][Full Text] [Related]
33. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
[TBL] [Abstract][Full Text] [Related]
34. Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.
Malempati S; Rodeberg DA; Donaldson SS; Lyden ER; Anderson JR; Hawkins DS; Arndt CA
Cancer; 2011 Aug; 117(15):3493-501. PubMed ID: 21264837
[TBL] [Abstract][Full Text] [Related]
35. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
Breneman J; Meza J; Donaldson SS; Raney RB; Wolden S; Michalski J; Laurie F; Rodeberg DA; Meyer W; Walterhouse D; Hawkins DS
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):720-6. PubMed ID: 22104356
[TBL] [Abstract][Full Text] [Related]
36. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
[TBL] [Abstract][Full Text] [Related]
37. Patterns of Failure in Pediatric Rhabdomyosarcoma After Proton Therapy.
Vern-Gross TZ; Indelicato DJ; Bradley JA; Rotondo RL
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1070-1077. PubMed ID: 27742542
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmic involvement as a presenting feature of nonorbital childhood parameningeal embryonal rhabdomyosarcoma.
Mullaney PB; Nabi NU; Thorner P; Buncic R
Ophthalmology; 2001 Jan; 108(1):179-82. PubMed ID: 11150285
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
Eaton BR; McDonald MW; Kim S; Marcus RB; Sutter AL; Chen Z; Esiashvili N
Cancer; 2013 Apr; 119(8):1578-85. PubMed ID: 23280478
[TBL] [Abstract][Full Text] [Related]
40. Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group.
Rosenberg AR; Anderson JR; Lyden E; Rodeberg DA; Wolden SL; Kao SC; Parham DM; Arndt C; Hawkins DS
Eur J Cancer; 2014 Mar; 50(4):816-23. PubMed ID: 24361229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
